Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Benign Fibrous Mesothelioma

imatinib mesylate has been researched along with Benign Fibrous Mesothelioma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morinaga, R; Otsu, S; Shirao, K; Watanabe, K1
Agostini, M; Colombo, P; de Braud, F; De Pas, T; Manzotti, M; Pelosi, G; Toffalorio, F; Trifirò, G; Vigna, PD1
Bonello, L; Bosco, M; Daniele, L; Filosso, P; Macri', L; Mussa, B; Prunotto, M; Rossi, G; Sapino, A; Schirosi, L1

Other Studies

3 other study(ies) available for imatinib mesylate and Benign Fibrous Mesothelioma

ArticleYear
CD34-negative solitary fibrous tumour resistant to imatinib.
    BMJ case reports, 2013, Jul-05, Volume: 2013

    Topics: Aged; Antigens, CD34; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Drug Resistance, Neoplasm; Fatal Outcome; Humans; Imatinib Mesylate; Male; Piperazines; Pyrimidines; Solitary Fibrous Tumor, Pleural; Tomography, X-Ray Computed

2013
Brief report: activity of imatinib in a patient with platelet-derived-growth-factor receptor positive malignant solitary fibrous tumor of the pleura.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008, Volume: 3, Issue:8

    Topics: Adult; Benzamides; Female; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Piperazines; Pleural Neoplasms; Pneumonectomy; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Solitary Fibrous Tumor, Pleural; Tomography, X-Ray Computed

2008
Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta.
    Lung cancer (Amsterdam, Netherlands), 2009, Volume: 64, Issue:2

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blotting, Western; Cell Proliferation; Cells, Cultured; Cisplatin; Female; Fluorescent Antibody Technique; Fluorouracil; Humans; Imatinib Mesylate; In Vitro Techniques; Neoplasm Recurrence, Local; Piperazines; Pneumonectomy; Pyrimidines; Radiotherapy; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Solitary Fibrous Tumor, Pleural

2009